Since the start of the pandemic, the effects of COVID-19 on expectant mothers have been unclear, yet worrisome. RGA's Dr. Nutan Wane reviews the latest research on its impact on pregnancy and childbirth. Read More

What factors are associated with risk of death from COVID-19? What does this mean for insurers? RGA's Anna Currie and John Ng provide an analysis of the recent OpenSAFELY study, the largest conducted to date by any country on COVID-19.  Read More

RGA's Data Insights team presents three different ways to visualize COVID-19 mortality rates for Italy and England in a hospital setting. Exploring data from countries that started to experience the pandemic sooner may help inform how mortality may develop in other coun... Read More

Do high levels of air pollution contribute to increased risk of severe illness and death in patients with COVID-19? RGA's Hilary Henly explains what ambient air pollution means for COVID-19 infection and death rates. Read More

COVID-19 appears to be much more fatal for men. RGA's Global Data and Analytics team analyzed the data across age groups and multiple countries to gain a clearer understanding of the relationship between age, sex, and COVID-19 mortality.

Read More

Could air pollution contribute to the risk of developing Alzheimer’s disease? Can mental stimulation and social connection protect against the cognitive decline? RGA's Hilary Henly explores lifestyle and environmental risk factors, explores genetic insights and testing ... Read More

RGA’s Eric Westhus explains the main categories of epidemiological models that have been developed by researchers around the world to study COVID-19.

Read More

Empathy, understanding, and proactive assistance are vital during challenging times, especially when human touchpoints in established processes are limited. Stephen Goldstein of RGAX, RGA’s transformation engine, explains how insurance professionals honing these sk... Read More

While researchers are working hard to understand the coronavirus's epidemiology, some studies suggest that genetics may play an important role. Carmela Tedesco of RGAX and RGA's Gayathri Ravi Shankar explain how genome studies could lead to more targeted therapeutic and... Read More

Do infection rates vary by age? In this article, RGA's Global Data and Analytics team studies estimates of pandemic experience in Spain and England so far, and uncovers remarkable differences. However, insurers need to bear in mind that these trends may look very d... Read More

The future of the COVID-19 pandemic is certainly muddy, with ongoing implications for claimant mental health, rehabilitation prospects, and claims duration. RGA's Dr. Adela Osman and Belinda Thorpe ask "How deep is the mud?" in the June 2020 edition of FA News.... Read More

Recently, a novel Kawasaki-like disease has been described as an emerging consequence of the COVID-19 infection. However, the association requires further investigation to better clarify the mechanisms behind this relationship. RGA's Dr. Paul Davis reviews the latest re... Read More

RGA's Colin DeForge considers what underwriters know and don’t know in the midst of the COVID-19 pandemic and offers practical steps on how to prevent fraudsters from taking advantage of this climate of uncertainty. 

This article is Part II in a series...

Read More

Chase Huey of RGAX, RGA’s transformation engine, explains how the implementation of the lean methodology can optimize processes and improve project success rates during the COVID-19 crisis.

Read More

The International Insurance Society (IIS) 55^th Global Insurance Forum attracts a diverse delegation of global insurance and reinsurance executives, regulators, academics and policymakers to discuss the issues that are shaping the future of the ins...

Read More

The past several decades have seen microbes become increasingly resistant to the modern arsenal of antimicrobial drugs, even as few new antimicrobial drugs have been discovered or developed. Against this backdrop, the drug-resistant fungus Candida auris (C. auris...

Read More

Who is at greatest risk of dying with COVID-19? One of the oldest mathematical formulations in actuarial science offers clues. RGA's Global Research and Data Analytics team demystifies the math behind current risk assessments by age and other factors. For more on this t... Read More

Are men dying from COVID-19 at a consistently higher rate? What is the relationship between the case fatality rate and age? RGA’s Global Research and Data Analytics team delves deep into publicly available data by age and sex, weighing country-specific uncertainties and... Read More

Could mental health be a casualty of quarantine and self-isolation measures aimed at curtailing the spread of COVID-19? RGA's Diana Bosworth explores rising reports of stress, anxiety, and depression, and identifies insurance product innovations aimed at helpi... Read More

Could the early 20th century remedy of plasma transfusions help fight the 21st century scourge of COVID-19? Dr. Jeffrey P. Henderson of Washington University is seeking to find out. The  Read More